Pedometer Activity Monitoring After ASCT (PAMAL)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03238599|
Recruitment Status : Recruiting
First Posted : August 3, 2017
Last Update Posted : January 14, 2020
|Condition or disease||Intervention/treatment||Phase|
|Lymphoma Myeloma High-dose Chemotherapy Autologous Stem Cell Transplantation||Behavioral: Pedometer-based activity monitoring after ASCT||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||168 participants|
|Intervention Model:||Single Group Assignment|
|Intervention Model Description:||Non-randomized prospective non-blinded single-arm clinical phase II study|
|Masking:||None (Open Label)|
|Official Title:||Clinical Trial Investigating Pedometer-based Activity Monitoring After Autologous Transplantation in Lymphoma and Myeloma Patients|
|Actual Study Start Date :||November 2, 2017|
|Estimated Primary Completion Date :||December 2021|
|Estimated Study Completion Date :||December 2021|
Experimental: Pedometer-based activity monitoring
The physical activity of patients after autologous transplantation for lymphoma and myeloma is measured with the pedometer
Behavioral: Pedometer-based activity monitoring after ASCT
Measurement of physical daily activity using a digital step counter (Pedometer-based activity monitoring) and assessment of patient well-being using a web-based patient reported tool.
- Professional Activity [ Time Frame: 100 days ]Number of patients who resumed their professional activity within 100 days after ASCT.
- Physical activity [ Time Frame: 100 days ]Web-based patient reported physical activity assessed by digital step counting after autologous transplant.
- Febrile Episodes [ Time Frame: 100 days ]Web-based patient reported febrile episodes after autologous transplant.
- Well-being [ Time Frame: 100 days ]Web-based patient reported well-being assessed by digital follow-up reporting after autologous transplant.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03238599
|Contact: Thomas Pabst, MD||+41 31 632 84 firstname.lastname@example.org|
|Departement of Medical Oncology, University Hospital Berne||Recruiting|
|Berne, Switzerland, 3010|
|Contact: Thomas Pabst, MD +41 31 632 84 30 email@example.com|
|Study Chair:||Thomas Pabst, MD||Departement of Medical Oncology, University Hospital Berne|